Question 1

Has Robert McWilliams, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $6,263,402 in general payments to Robert McWilliams, MD across 171 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Robert McWilliams, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Robert McWilliams, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
GSK	75	$4,105,781
Merck	55	$1,888,053
Genentech, Inc.	29	$99,744
Novartis	2	$98,822
Pfizer	1	$35,900
Ipsen Bioscience Inc.	2	$21,350
Bristol Myers Squibb	3	$11,521
Organon	2	$1,178
E.r. Squibb & Sons, L.L.C.	2	$1,053

Robert McWilliams, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other medical oncology in Rochester